INDEX. 781 



PAGE 



8 pi rochet a obermeieri 25, 642 



Animals, susceptibility of, 643 ; antiserums, properties 

 of. 644 ; distributum in the body, 643 ; morphology, 

 642 ; occurrence in bedbugs, 643 ; phagocytosis of, 

 644, 645 ; see Relapsing fever. 



Spotted fever 73, 720-725 



Immunity in, tf25 ; maintenance of, 723 ; micro- 

 organisms in, 724 ; pyroplasma hominis in, 720 ; 

 transmission to man, 722 ; to other animals, 722 ; 

 transmission by ticks, 721, 723. 



Staphylococcus pyogenes, or staphylococcus 537-550 



Agglutination, 206, 549 ; amyloid degeneration, 542 : 

 animals, susceptibility of, 543 ; antiserums, prop- 

 erties, 547 ; bactericidal action of leucocytic exu- 

 dates, 546 ; bacteriolysin, 546. 547 ; discovery, 516 : 

 endotoxin, 540 ; ferments of, 538 ; hernolytic action. 



538, 539 ; immunity, 316. 546, 547 ; leucocidin, 



539, 547, 549 : leucocytes in infections, 545, 546 ; 

 leucotactic substance, 542 ; mixed infections, 545 ; 

 morphology, 537 ; necrotizing substance, 542 ; path- 

 ogenic powers, 139, 501, 510, 520, 525, 543, 544, 

 556 ; opsonins in phagocytosis of, 549 ; phagocy- 

 tosis, 545, 546, 548 ; pigment formation, 541 ; poly- 

 valent serum. 550 ; resistance, 541, 542 ; staphy- 

 lolysin, 435, 539, 542, 547 ; symbiosis with Ameba 

 coli, 687 ; symbiosis with B. influenza, 564 : toxicity 

 of culture filtrates, 539, 540 ; toxin, soluble, 542 ; 

 vaccination against, 548 ; varieties, 540, 541 ; viru- 

 lence, 543. 



Staphylolysin ; see Staphylococcus. 



Btegomyia fasciata and its relation to yellow fever.... 713 



Streptococci in scarlet fever 26, 520, 523, 527 



Streptococcus brevis 516 



Streptococcus erysipelatis 516 



Streptococcus longus 516 



Streptococcus mucosus capsulatus 516 



Streptococcus pyogenes 517-537 



Agglutination, 206, 536, 537 ; animals, susceptibility 

 of, 518 ; antagonism for B. anthracis, 494, 528 ; for B. 

 tuberculosis, 522 ; antistreptococcus serum, properties 

 of, 529, 535 ; antistreptocolysin, 519 ; Coley's mixture. 

 529 ; cultivation. 517 ; in diphtheria, 401, 524 ; discov- 

 ery, 515 ; endotoxin, 518 ; erysipelas, 515, 520, 521 ; 

 immunity, 316. 529, 530. 531 ; infection atria, 524 ; in- 

 fections, miscellaneous, 520, 529 ; in influenza, 567 ; 

 leucocytes and leucocytosis, 530, 531 ; in meningitis, 



520, 557 ; in milk, 523 ; morphology, 515 ; opsonins, 

 531 ; phagocytosis, 530, 531 ; in pneumonia, 501, 

 510, 520, 521. 522 ; resemblance to pneumococcus, 

 503 ; resistance, 517 ; in rheumatic fever, 520 359 ; 

 in scarlet fever, 26, 520, 521, 533 ; serotherapy, 

 534-536 ; serums, univalent and polyvalent, 533 ; 

 streptocolysin, 519, 520 ; symbiosis with B. inflii- 

 enzce, 564 ; tissue reactions, 144 ; toxic properties, 

 519, 520, 529 ; toxin for erythrocytes ; see Strepto- 

 colysin ; toxin for leucocytes, 519 ; in tuberculosis, 



521, 522, 591, 592 ; tumors, influence on, 529 ; in 

 typhoid fever, 439 ; unity, question of, 532 ; varie- 

 ties, 516 ; virulence, 518. 



Streptococcus scarlatina 527 



Streptocolysin 519, 520 



Streptothrix, infections with 634 



Streptothriw madurce 634 



